1. Home
  2. ETON vs METC Comparison

ETON vs METC Comparison

Compare ETON & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • METC
  • Stock Information
  • Founded
  • ETON 2017
  • METC 2015
  • Country
  • ETON United States
  • METC United States
  • Employees
  • ETON N/A
  • METC N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • ETON Health Care
  • METC Energy
  • Exchange
  • ETON Nasdaq
  • METC Nasdaq
  • Market Cap
  • ETON 428.5M
  • METC 514.2M
  • IPO Year
  • ETON 2018
  • METC 2017
  • Fundamental
  • Price
  • ETON $13.75
  • METC $11.50
  • Analyst Decision
  • ETON Strong Buy
  • METC Strong Buy
  • Analyst Count
  • ETON 3
  • METC 3
  • Target Price
  • ETON $29.67
  • METC $13.67
  • AVG Volume (30 Days)
  • ETON 457.7K
  • METC 875.8K
  • Earning Date
  • ETON 08-07-2025
  • METC 08-06-2025
  • Dividend Yield
  • ETON N/A
  • METC 4.81%
  • EPS Growth
  • ETON N/A
  • METC N/A
  • EPS
  • ETON N/A
  • METC N/A
  • Revenue
  • ETON $48,327,000.00
  • METC $628,275,000.00
  • Revenue This Year
  • ETON $103.21
  • METC N/A
  • Revenue Next Year
  • ETON $51.34
  • METC $25.50
  • P/E Ratio
  • ETON N/A
  • METC N/A
  • Revenue Growth
  • ETON 40.88
  • METC N/A
  • 52 Week Low
  • ETON $3.19
  • METC $5.90
  • 52 Week High
  • ETON $21.48
  • METC $14.15
  • Technical
  • Relative Strength Index (RSI)
  • ETON 26.60
  • METC 62.73
  • Support Level
  • ETON $13.09
  • METC $10.60
  • Resistance Level
  • ETON $14.18
  • METC $11.68
  • Average True Range (ATR)
  • ETON 0.78
  • METC 0.74
  • MACD
  • ETON -0.23
  • METC 0.09
  • Stochastic Oscillator
  • ETON 8.78
  • METC 75.61

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: